Evidence map›Paper›PMID 25183735›Full record

ArticleInfection and immunity2014

Bacterial lysis liberates the neutrophil migration suppressor YbcL from the periplasm of uropathogenic Escherichia coli.

Megan E Lau, Elizabeth S Danka, Kristin M Tiemann, David A Hunstad

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Urinary Tract Infection: Pathogenesis and Outlook.Trends in molecular medicine · 2016
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Megan E LauDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Elizabeth S DankaDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
Kristin M TiemannDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
David A HunstadDepartment of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA dhunstad@wustl.edu.
Washington University in St. Louis · US

Funding

pan-Genome of E.coli in the bladder and gut of women with recurrent UTIP50DK064540 · NIDDK · WASHINGTON UNIVERSITY · PI HULTGREN, SCOTT J. · 2002 to 2017
$17.9M
THE OUTER MEMBRANE AS A VIRULENCE PLATFORMR01DK080752 · NIDDK · WASHINGTON UNIVERSITY · PI HUNSTAD, DAVID · 2009 to 2013
$1.5M
Targeting the E. coli chaperone SurA in recurrent UTIR03DK076556 · NIDDK · WASHINGTON UNIVERSITY · PI HUNSTAD, DAVID · 2007 to 2008
$151k
NIDDK NIH HHS P50 DK064540NIDDK NIH HHS P50-DK064540NIDDK NIH HHS R01 DK080752NIDDK NIH HHS R01-DK080752NIDDK NIH HHS R03 DK076556NIDDK NIH HHS R03-DK076556
6 · The paper itself

Abstract

Uropathogenic Escherichia coli (UPEC) modulates aspects of the innate immune response during urinary tract infection to facilitate bacterial invasion of the bladder epithelium, a requirement for the propagation of infection. For example, UPEC-encoded YbcL suppresses the traversal of bladder epithelia by neutrophils in both an in vitro model and an in vivo murine cystitis model. The suppressive activity of YbcL requires liberation from the bacterial periplasm, though the mechanism of release is undefined. Here we present findings on the site of action of YbcL and demonstrate a novel mode of secretion for a UPEC exoprotein. Suppression of neutrophil migration by purified YbcL(UTI), encoded by cystitis isolate UTI89, required the presence of a uroepithelial layer; YbcL(UTI) did not inhibit neutrophil chemotaxis directly. YbcL(UTI) was released to a greater extent during UPEC infection of uroepithelial cells than during that of neutrophils. Release of YbcL(UTI) was maximal when UPEC and bladder epithelial cells were in close proximity. Established modes of secretion, including outer membrane vesicles, the type II secretion system, and the type IV pilus, were dispensable for YbcL(UTI) release from UPEC. Instead, YbcL(UTI) was liberated during bacterial death, which was augmented upon exposure to bladder epithelial cells, as confirmed by detection of bacterial cytoplasmic proteins and DNA in the supernatant and enumeration of bacteria with compromised membranes. As YbcL(UTI) acts on the uroepithelium to attenuate neutrophil migration, this mode of release may represent a type of altruistic cooperation within a UPEC population during colonization of the urinary tract.

Indexed as

Immune System DiseasesLeukocyte DisordersAdultCarrier ProteinsEpithelial CellsEscherichia coli ProteinsHumansImmunosuppressive AgentsNeutrophilsPeriplasmic ProteinsUropathogenic Escherichia coliCarrier ProteinsEscherichia coli ProteinsImmunosuppressive AgentsPeriplasmic ProteinsybcL protein, E coli

Identifiers

PMID25183735
PMCPMC4249291
OpenAlexW2167361325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.